In the latest episode of Med Tech Talks, Robert Klupacs is joined by Dr Chris Smith, a partner at Brandon Capital - Australasia's leading life science venture capital firm.

Chris has extensive experience in the global biotech industry. With a PhD in immunology and an MBA specialising in innovation and entrepreneurship from the University of Cambridge; he has also previously been a business development manager with CSL; and is currently a Director of Aravax, Denteric, Ena Respiratory, MycRx, Q-Sera and Axelia Oncology, just to name a few.

In this episode, you will hear more about:

Tips for pitching to investors and building a relationship with venture capital firms
Demystifying the role of a VC in research and development
Brandon Capital’s incubator approach to risk and investing in early-stage innovations.

Learn about Dr Chris Smith

Visit the Brandon Capital website

Updated version 05/08/22

Insights into innovation investment from venture capitalist Dr Chris Smith